How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma |
| |
| Authors: | Florian Hucke,Matthias Pinter,Ivo Graziadei,Simona Bota,Wolfgang Vogel,Christian Mü ller,Harald Heinzl,Fredrik Waneck,Michael Trauner,Markus Peck-Radosavljevic,Wolfgang Sieghart |
| |
| Affiliation: | 1 Division of Gastroenterology and Hepatology, Department of Internal Medicine III, AKH & Medical University of Vienna, Austria;2 Department of Gastroenterology and Hepatology, LKH & Medical University of Innsbruck, Austria;3 Section for Clinical Biometrics, Medical University of Vienna, Austria;4 Department of Interventional Radiology, Medical University of Vienna, Austria |
| |
| Abstract: | |
| |
| Keywords: | TACE, transarterial chemoembolization HCC, hepatocellular carcinoma OS, overall survival ART, Assessment for Retreatment with TACE CRP, C-reactive protein BCLC, Barcelona Clinic Liver Cancer PEI, percutaneous ethanol injection RFA, radiofrequency ablation UICC, Union for International Cancer Control TNM, tumour node metastasis HAP, hepatoma arterial-embolisation prognostic PR, partial response CR, complete response SD, stable disease PD, progressive disease AFP, alpha-fetoprotein MELD, model for end-stage liver disease |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
